Identifier	Name	colname	Synonyms	Action	Clinical.Stage	Putative.Target	Targeted.process.pathway	PubChem_CID	PubChem_SMILES	filename	PubChem	remark
211	TL-2-105	TL-2-105		targeted	experimental	CRAF	ERK MAPK signaling	NA	NA	TL-2-105	NA	
221	TAK-715	TAK-715	KIN001-201	targeted	in clinical development	p38a	JNK and p38 signaling	9952773	CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC(=C4)C	TAK-715	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9952773"" target= ""_blank"">PubChem</a>"	
152	CP466722	CP466722		targeted	experimental	ATM	Genome integrity	44551660	COC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC	CP466722	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44551660"" target= ""_blank"">PubChem</a>"	
203	BMS-345541	BMS-345541		targeted	experimental	IKBKB	other	9813758	CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN	BMS-345541	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9813758"" target= ""_blank"">PubChem</a>"	
225	Genentech Cpd 10	Genentech_Cpd_10		targeted	experimental	"AURKA, AURKB"	mitosis	92131181	[2H]C([2H])(CC1CCN(CC1)C2=NC3=NC4=CC=CC=C4N3C=C2)[18F]  	Genentech_Cpd_10	https://pubchem.ncbi.nlm.nih.gov/compound/92131181	Updated
230	GSK429286A	GSK429286A		targeted	experimental	ROCK2	cytoskeleton	11373846	CC1=C(C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(C=C4C(=C3)C=NN4)F	GSK429286A	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11373846"" target= ""_blank"">PubChem</a>"	
206	Ruxolitinib	Ruxolitinib	"Jakafi, INCB-18424"	targeted	clinically approved	"JAK1, JAK2, TYK2"	other	25126798	C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3	Ruxolitinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25126798"" target= ""_blank"">PubChem</a>"	
208	SB-715992	SB-715992	SB-715992	targeted	in clinical development	KIF11	mitosis	6450816	CC1=CC=C(C=C1)C(=O)N(CCCN)[C@@H](C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C.CS(=O)(=O)O	SB-715992	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6450816"" target= ""_blank"">PubChem</a>"	
223	ZSTK474	ZSTK474	KIN001-167	targeted	in clinical development	PI3K	PI3K signaling	11647372	C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5	ZSTK474	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11647372"" target= ""_blank"">PubChem</a>"	
228	KIN001-102	KIN001-102		targeted	experimental	AKT1	PI3K signaling	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-102	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	Updated
238	CAL-101	CAL-101		targeted	clinically approved	PI3Kdelta	PI3K signaling	11625818	CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	CAL-101	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11625818"" target= ""_blank"">PubChem</a>"	
193	GW-2580	GW-2580		targeted	experimental	CSF1R (cFMS)	RTK signaling	11617559	COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC	GW-2580	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11617559"" target= ""_blank"">PubChem</a>"	
205	BMS-708163	BMS-708163	Avagacestat	targeted	in clinical development	g-secretase	other	46883536	C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl	BMS-708163	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46883536"" target= ""_blank"">PubChem</a>"	
222	BX-912	BX-912	KIN001-175	targeted	experimental	PDPK1 (PDK1)	PI3K signaling	11754511	C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br	BX-912		
229	LY317615	LY317615	Enzastaurin	targeted	in clinical development	PRKCB (PKCbeta)	other	176167	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7	LY317615	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/176167"" target= ""_blank"">PubChem</a>"	
252	WZ3105	WZ3105		targeted	experimental	"CLK2, CNSK1E, FLT3, ULK1"	other	NA	NA	WZ3105	NA	Compount not found
253	XMD14-99	XMD14-99		targeted	experimental	"EPHB3, CAMK1"	RTK signaling	NA	NA	XMD14-99	NA	Compount not found
255	CP724714	CP724714		targeted	in clinical development	ERBB2	EGFR signaling	9874913	CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C	CP724714	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9874913"" target= ""_blank"">PubChem</a>"	
256	JW-7-24-1	JW-7-24-1		targeted	experimental	LCK	other	NA	NA	JW-7-24-1	NA	Compount not found
277	ABT-869	ABT-869	Linifanib	targeted	in clinical development	VEGFR and PDGFR family	RTK signaling	11485656	CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N	ABT-869	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11485656"" target= ""_blank"">PubChem</a>"	
283	GSK2126458	GSK2126458	EX-8678	targeted	in clinical development	"PI3K, MTOR"	PI3K signaling	25167777	COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F	GSK2126458	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25167777"" target= ""_blank"">PubChem</a>"	
301	PHA-793887	PHA-793887		targeted	experimental	CDK-pan	cell cycle	46191454	CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C	PHA-793887	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46191454"" target= ""_blank"">PubChem</a>"	
306	TG101348	TG101348		targeted	in clinical development	JAK2	other	16722836	CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4	TG101348	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16722836"" target= ""_blank"">PubChem</a>"	
329	QL-XI-92	QL-XI-92		targeted	experimental	DDR1	RTK signaling	NA	NA	QL-XI-92	NA	Compount not found
332	XMD15-27	XMD15-27		targeted	experimental	"CAMK2B, CLK2, DYRK1A, MAST1, STK39"	other	NA	NA	XMD15-27	NA	Compount not found
235	QL-XII-47	QL-XII-47		targeted	experimental	"BTK, BMX"	other	118346216	CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6CC=CCN(C)CC#C)C=C5	QL-XII-47	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/118346216"" target= ""_blank"">PubChem</a>"	Updated
254	AC220	AC220	Quizartinib	targeted	in clinical development	FLT3	RTK signaling	24889392	CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3	AC220	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24889392"" target= ""_blank"">PubChem</a>"	
282	EKB-569	EKB-569	Pelitinib	targeted	in clinical development	EGFR	EGFR signaling	6445562	CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C	EKB-569	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6445562"" target= ""_blank"">PubChem</a>"	
292	Masitinib	Masitinib	AB1010	targeted	clinically approved	KIT	RTK signaling	10074640	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5	Masitinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10074640"" target= ""_blank"">PubChem</a>"	
298	OSI-930	OSI-930		targeted	in clinical development	"KIT, VEGFR, PDGFR"	RTK signaling	114845	O=S 	OSI-930	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/114845"" target= ""_blank"">PubChem</a>"	
330	XMD13-2	XMD13-2		targeted	experimental	RIPK	other	NA	NA	XMD13-2	NA	Compount not found
1378	Bleomycin (50 uM)	Bleomycin_(50_uM)		cytotoxic	clinically approved	DNA damage	DNA replication	5460769	CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O	Bleomycin_(50_uM)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5460769"" target= ""_blank"">PubChem</a>"	Compount not found
219	AT-7519	AT-7519		targeted	in clinical development	CDK9	cell cycle	11338033	C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl	AT-7519	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11338033"" target= ""_blank"">PubChem</a>"	
249	XL-184	XL-184	"Cometriq, Cabozantinib"	targeted	clinically approved	"VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, Tie2,AXL"	RTK signaling	25102847	COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F	XL-184	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25102847"" target= ""_blank"">PubChem</a>"	
257	NPK76-II-72-1	NPK76-II-72-1		targeted	experimental	PLK3	mitosis	NA	NA	NPK76-II-72-1	NA	Compount not found
260	NG-25	NG-25		targeted	experimental	MAP3K7 (TAK1)	other	53340664	CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)OC4=C5C=CNC5=NC=C4)C(F)(F)F	NG-25	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/53340664"" target= ""_blank"">PubChem</a>"	
261	TL-1-85	TL-1-85		targeted	experimental	MAP3K7 (TAK1)	other	NA	NA	TL-1-85	NA	Compount not found
262	VX-11e	VX-11e		targeted	experimental	ERK	ERK MAPK signaling	11634725	CC1=CN=C(N=C1C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)NC4=C(C=C(C=C4)F)Cl	VX-11e	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11634725"" target= ""_blank"">PubChem</a>"	
263	FR-180204	FR-180204		targeted	experimental	ERK	ERK MAPK signaling	11493598	C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N	FR-180204	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11493598"" target= ""_blank"">PubChem</a>"	
266	Zibotentan	"Zibotentan,_ZD4054"	ZD4054	targeted	in clinical development	Endothelin A Receptor	other	9910224	CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4	"Zibotentan,_ZD4054"	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9910224"" target= ""_blank"">PubChem</a>"	
279	BIX02189	BIX02189		targeted	experimental	MAP2K5 (MEK5)	other	135659062	CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O	BIX02189	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135659062"" target= ""_blank"">PubChem</a>"	Updated
286	KIN001-236	KIN001-236		targeted	experimental	TIE2	other	157400995	[N-]=[N+]=[N-].[K+].[I-] 	KIN001-236	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	Updated
288	KIN001-055	KIN001-055	"WHI-P97, AC1L1GQE"	targeted	experimental	"JAK3, MNK1"	other	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-055	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995  "" target= ""_blank"">PubChem</a>Updated"	
291	KIN001-266	KIN001-266		targeted	experimental	MAP3K8 (COT)	other	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-266	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	Updated
295	NVP-BHG712	NVP-BHG712		targeted	experimental	EPHB4	RTK signaling	16747388	CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=C4C=NN(C4=NC(=N3)C5=CN=CC=C5)C	NVP-BHG712	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16747388"" target= ""_blank"">PubChem</a>"	Updated
303	PIK-93	PIK-93		targeted	experimental	"PI4K, PI3K"	PI3K signaling	140656136	[P-2]I 	PIK-93	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/140656136 "" target= ""_blank"">PubChem</a>"	Updated
305	TPCA-1	TPCA-1		targeted	experimental	IKK	other	9903786	C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F	TPCA-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9903786"" target= ""_blank"">PubChem</a>"	
309	Y-39983	Y-39983		targeted	experimental	ROCK	cytoskeleton	9810884	C[C@H](C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N	Y-39983	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9810884"" target= ""_blank"">PubChem</a>"	
310	YM201636	YM201636		targeted	experimental	FYV1	other	9956222	C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N	YM201636	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9956222"" target= ""_blank"">PubChem</a>"	
312	AV-951	AV-951	Tivozanib	targeted	in clinical development	VEGFR	RTK signaling	9911830	CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl	AV-951	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9911830"" target= ""_blank"">PubChem</a>"	
326	GSK690693	GSK690693		targeted	experimental	AKT	PI3K signaling	16725726	CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N	GSK690693	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16725726"" target= ""_blank"">PubChem</a>"	
345	KIN001-270	KIN001-270		targeted	experimental	CDK9	cell cycle	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-270	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	
281	CH5424802	CH5424802		targeted	in clinical development	ALK	RTK signaling	49806720	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C	CH5424802	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/49806720"" target= ""_blank"">PubChem</a>"	
287	KIN001-244	KIN001-244		targeted	experimental	PDPK1 (PDK1)	PI3K signaling	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-244	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	Updated
290	KIN001-260	KIN001-260	Bayer IKKb inhibitor	targeted	experimental	IKK	other	157400995	[N-]=[N+]=[N-].[K+].[I-]	KIN001-260	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/157400995"" target= ""_blank"">PubChem</a>"	Updated
304	SB52334	SB52334		targeted	experimental	ALK5	RTK signaling	97489	C1=CC=C(C=C1)C2=C(C=CC=N2)C(=O)O	SB52334	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/97489"" target= ""_blank"">PubChem</a>"	Updated
224	AS605240	AS605240	KIN001-173	targeted	experimental	PI3Kgamma	PI3K signaling	5289247	C1=CC2=NC=CN=C2C=C1/C=C\3/C(=O)NC(=O)S3	AS605240	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5289247"" target= ""_blank"">PubChem</a>"	Updated
258	STF-62247	STF-62247		not defined	experimental	stimulates autophagy	other	704473	CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3	STF-62247	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/704473"" target= ""_blank"">PubChem</a>"	
275	I-BET-762	I-BET	GSK525762A	targeted	experimental	"BRD2, BRD3, BRD4"	chromatin  other	46943432	CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C	I-BET	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46943432"" target= ""_blank"">PubChem</a>"	
294	MPS-1-IN-1	MPS-1-IN-1		targeted	experimental	MPS1	mitosis	25195352	CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC	MPS-1-IN-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25195352"" target= ""_blank"">PubChem</a>"	Compount not found
300	CX-5461	CX-5461		targeted	experimental	RNA Pol I	other	25257557	CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C	CX-5461	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25257557"" target= ""_blank"">PubChem</a>"	
265	Tubastatin A	Tubastatin_A		targeted	experimental	HDAC6	chromain  histone acetylation	49850262	CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO	Tubastatin_A	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/49850262 "" target= ""_blank"">PubChem</a>"	Updated
271	VNLG/124	VNLG/124		targeted	experimental	"HDAC, RAR "	chromain  histone acetylation	24894414	CCCC(=O)OCC1=CC=C(C=C1)OC(=O)/C=C(\\C)/C=C/C=C(\\C)/C=C/C2=C(CCCC2(C)C)C	VNLG_124	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24894414"" target= ""_blank"">PubChem</a>"	Compount not found
308	XL-880	XL-880	"Foretinib, GSK1363089"	targeted	in clinical development	MET	RTK signaling	42642645	COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F	XL-880	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/42642645"" target= ""_blank"">PubChem</a>"	
341	EX-527	EX-527		targeted	experimental	SIRT1	other	5113032	C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N	EX-527	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5113032"" target= ""_blank"">PubChem</a>"	
344	THZ-2-49	THZ-2-49		targeted	experimental	CDK9	cell cycle	NA	NA	THZ-2-49	NA	Compount not found
1219	PFI-1	PFI-1		targeted	experimental	"BRD2, BRD3, BRD4"	chromatin  other	71271629	CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O	PFI-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/71271629"" target= ""_blank"">PubChem</a>"	Compount not found.Nothing in the best search
245	UNC0638	UNC0638		targeted	experimental	"G9a(EHMT2), GLP(EHMT1)"	chromatin  histone methylation	46224516	CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5	UNC0638	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46224516"" target= ""_blank"">PubChem</a>"	Compound not found
245	UNC0638	UNC0638		targeted	experimental	"G9a(EHMT2), GLP(EHMT1)"	chromatin  histone methylation	46224516	CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5	UNC0638	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46224516"" target= ""_blank"">PubChem</a>"	Compound not found
299	OSI-027	OSI-027	A-1065	targeted	in clinical development	MTORC1/2	TOR signaling	44224160	COC1=CC=CC2=C/C(=C/3\C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)/N=C21	OSI-027	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44224160"" target= ""_blank"">PubChem</a>"	Compound not found. Nothing in the best match
1494	SN-38	SN-38	7-ethyl-10-hydroxy-camptothecin	cytotoxic	experimental	TOP1	DNA replication	104842	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O	SN-38	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/104842"" target= ""_blank"">PubChem</a>"	Compound not found. Nothing in the best match
293	MP470	MP470		targeted	in clinical development	PDGFR	RTK signaling	11282283	C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6	MP470	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11282283"" target= ""_blank"">PubChem</a>"	
333	T0901317	T0901317		targeted	experimental	LXR	other	447912	C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O	T0901317	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/447912"" target= ""_blank"">PubChem</a>"	
1230	IOX2	IOX2		targeted	experimental	EGLN1	other	54685215	C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O	IOX2	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/54685215"" target= ""_blank"">PubChem</a>"	
179	5-Fluorouracil	5-Fluorouracil	5-FU	cytotoxic	clinically approved	DNA antimetabolite	DNA replication	3385	C1=C(C(=O)NC(=O)N1)F	5-Fluorouracil	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/3385"" target= ""_blank"">PubChem</a>"	
269	NSC-207895	NSC-207895	XI-006	targeted	experimental	MDM4	p53 pathway	42640	CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-]	NSC-207895	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/42640"" target= ""_blank"">PubChem</a>"	
276	CAY10603	CAY10603		targeted	experimental	HDAC6	chromain  histone acetylation	24951314	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	CAY10603	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24951314"" target= ""_blank"">PubChem</a>"	
127	GSK269962A	GSK269962A	KIN001-155	targeted	experimental	"ROCK1, ROCK2"	cytoskeleton	16095342	CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6	GSK269962A	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16095342"" target= ""_blank"">PubChem</a>"	
1194	SB-505124	SB-505124		targeted	experimental	TGFR1 (ALK5)	other	9858940	CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4	SB-505124	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9858940"" target= ""_blank"">PubChem</a>"	
1199	Tamoxifen	Tamoxifen		targeted	clinically approved	ER	other	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Tamoxifen	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/2733526"" target= ""_blank"">PubChem</a>"	
1243	piperlongumine	piperlongumine		not defined	experimental	Increases ROS levels	other	637858	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCC=CC2=O	piperlongumine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/637858"" target= ""_blank"">PubChem</a>"	
302	PI-103	PI-103		targeted	experimental	"PI3Ka, PRKDC (DNAPK)"	PI3K signaling	9884685	C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O	PI-103	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9884685"" target= ""_blank"">PubChem</a>"	Compound not found. Nothing in the best match
196	Phenformin	Phenformin		targeted	experimental	AAPK1 (AMPK) agonist	metabolism	8249	C1=CC=C(C=C1)CCN=C(N)N=C(N)N	Phenformin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/8249"" target= ""_blank"">PubChem</a>"	
328	SNX-2112	SNX-2112		targeted	experimental	HSP90	other	24772860	CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C	SNX-2112	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24772860"" target= ""_blank"">PubChem</a>"	
205	BMS-708163	BMS-708163	Avagacestat	targeted	in clinical development	g-secretase	other	46883536	C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl	BMS-708163	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46883536"" target= ""_blank"">PubChem</a>"	
62	BMS-536924	BMS-536924	KIN001-126	targeted	experimental	IGF1R	IGFR signaling	135440466	CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5	BMS-536924	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135440466 "" target= ""_blank"">PubChem</a>"	
272	AR-42	AR-42	HDAC-42	targeted	in clinical development	HDAC	chromain  histone acetylation	6918848	CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO	AR-42	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6918848"" target= ""_blank"">PubChem</a>"	
1069	EHT 1864	EHT_1864		targeted	experimental	Rac GTPases	cytoskeleton	9938202	C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl	EHT_1864	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9938202"" target= ""_blank"">PubChem</a>"	
331	QL-X-138	QL-X-138		targeted	experimental	"MNK2, PRKDC (DNAPK), MTOR, BTK, JAK3"	other	73707530	CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C	QL-X-138	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/73707530"" target= ""_blank"">PubChem</a>"	
1067	CCT007093	CCT007093		targeted	experimental	PPM1D	other	2314623	C1/C(=C\C2=CC=CS2)/C(=O)/C(=C/C3=CC=CS3)/C1	CCT007093	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/2314623"" target= ""_blank"">PubChem</a>"	Updated
1175	AG-014699	AG-014699	PF-01367338	targeted	experimental	"PARP1, PARP2"	Genome integrity	9931953	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2.OP(=O)(O)O	AG-014699	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9931953"" target= ""_blank"">PubChem</a>"	
1062	AZD6244	AZD6244	selumetinib	targeted	in clinical development	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	10127622	CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO	AZD6244	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10127622"" target= ""_blank"">PubChem</a>"	
1149	TW 37	TW_37		targeted	experimental	"BCL2, BCL2L1"	apoptosis regulation	11455910	CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C	TW_37	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11455910"" target= ""_blank"">PubChem</a>"	Compound not found
1261	rTRAIL	rTRAIL		targeted	experimental	"TR10A (DR4),  TR10B (DR5)"	apoptosis regulation	NA	NA	rTRAIL	NA	
1268	XAV 939	XAV_939	NVP-XAV939	targeted	experimental	TNKS1 (tankyrase-1)	WNT signaling	135418940	C1CSCC2=C1N=C(NC2=O)C3=CC=C(C=C3)C(F)(F)F	XAV_939	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135418940 "" target= ""_blank"">PubChem</a>"	
1133	JNJ-26854165	JNJ-26854165	Serdemetan	targeted	in clinical development	MDM2	p53 pathway	11609586	C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4	JNJ-26854165	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11609586"" target= ""_blank"">PubChem</a>"	
1371	PLX4720 (rescreen)	PLX4720_(rescreen)	"Vemurafenib analog, Zelboraf (derivative)"	targeted	experimental	BRAF	ERK MAPK signaling	24180719	CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F	PLX4720_(rescreen)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24180719"" target= ""_blank"">PubChem</a>"	
273	CUDC-101	CUDC-101		targeted	in clinical development	"HDAC, EGFR"	chromain  histone acetylation	24756910	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO	CUDC-101	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24756910"" target= ""_blank"">PubChem</a>"	
346	THZ-2-102-1	THZ-2-102-1		targeted	experimental	CDK7	cell cycle	NA	NA	THZ-2-102-1	NA	Compound not found
1242	(5Z)-7-Oxozeaenol	(5Z)-7-Oxozeaenol		targeted	experimental	MAP3K7 (TAK1)	other	9863776	C[C@H]1C/C=C\C(=O)[C@H]([C@H](C/C=C/C2=C(C(=CC(=C2)OC)O)C(=O)O1)O)O	(5Z)-7-Oxozeaenol	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9863776"" target= ""_blank"">PubChem</a>"	
163	JQ1	JQ1		targeted	experimental	BRD4	chromatin  other	46907787	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C	JQ1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46907787"" target= ""_blank"">PubChem</a>"	
154	CHIR-99021	CHIR-99021	CT 99021	targeted	experimental	GSK3B	WNT signaling	9956119	CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N	CHIR-99021	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9956119"" target= ""_blank"">PubChem</a>"	
1259	BMN-673	BMN-673	Talazoparib	targeted	experimental	PARP1	Genome integrity	135565082	CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F	BMN-673	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135565082  "" target= ""_blank"">PubChem</a>"	Updated
1377	Afatinib (rescreen)	Afatinib_(rescreen)	"Gilotrif, BIBW2992, Tovok"	targeted	clinically approved	"ERBB2, EGFR"	EGFR signaling	10184653	CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4	Afatinib_(rescreen)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10184653"" target= ""_blank"">PubChem</a>"	
1262	UNC1215	UNC1215		targeted	experimental	LMBL3	other	57339144	C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6	UNC1215	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/57339144"" target= ""_blank"">PubChem</a>"	Compound not found
1264	SGC0946	SGC0946		targeted	experimental	Q8TEK3 (DOT1L)	chromatin  histone methylation	56962337	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O	SGC0946	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/56962337"" target= ""_blank"">PubChem</a>"	
1375	Temozolomide	Temozolomide	Temodar	cytotoxic	clinically approved	DNA akylating agent	DNA replication	5394	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	Temozolomide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5394"" target= ""_blank"">PubChem</a>"	
226	GSK1070916	GSK1070916		targeted	in clinical development	AURKB	mitosis	46885626	CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C	GSK1070916	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46885626"" target= ""_blank"">PubChem</a>"	
274	Belinostat	"PXD101,_Belinostat"	PXD101	targeted	clinically approved	HDAC	chromain  histone acetylation	6918638	C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO	"PXD101,_Belinostat"	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6918638"" target= ""_blank"">PubChem</a>"	
1129	PF-4708671	PF-4708671		targeted	experimental	RPS6KB1 (p70S6KA)	TOR signaling	51371303	CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F	PF-4708671	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/51371303"" target= ""_blank"">PubChem</a>"	
1495	Olaparib	Olaparib_(rescreen)	"Lynparza, KU0059436, AZD-2281"	targeted	clinically approved	"PARP1, PARP2"	Genome integrity	23725625	C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F	Olaparib_(rescreen)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/23725625"" target= ""_blank"">PubChem</a>"	
268	YM155	YM155	Sepantronium bromide	targeted	in clinical development	BIRC5 (Survivin)	apoptosis regulation	11178236	CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-]	YM155	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11178236"" target= ""_blank"">PubChem</a>"	
1248	FK866	FK866	APO866	targeted	experimental	NAMPT	metabolism	6914657	C1CN(CCC1CCCCNC(=O)/C=C/C2=CN=CC=C2)C(=O)C3=CC=CC=C3	FK866	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6914657"" target= ""_blank"">PubChem</a>"	Compound not found.
156	AZD6482	AZD6482	KIN001-193	targeted	in clinical development	PI3Kbeta	PI3K signaling	44137675	CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4	AZD6482	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44137675"" target= ""_blank"">PubChem</a>"	
134	Etoposide	Etoposide	Etophophos	cytotoxic	clinically approved	TOP2	DNA replication	36462	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	Etoposide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/36462"" target= ""_blank"">PubChem</a>"	
140	Vinorelbine	Vinorelbine	Navelbine	cytotoxic	clinically approved	Microtubules	cytoskeleton	5311497	CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC	Vinorelbine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5311497"" target= ""_blank"">PubChem</a>"	
153	Midostaurin	Midostaurin	PKC 412	targeted	in clinical development	KIT	RTK signaling	9829523	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC	Midostaurin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9829523"" target= ""_blank"">PubChem</a>"	
1170	CCT018159	CCT018159		targeted	experimental	HSP90	other	984170	CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C	CCT018159	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/984170"" target= ""_blank"">PubChem</a>"	Updated
155	AP-24534	AP-24534	"Ponatinib, KIN001-192"	targeted	in clinical development	ABL	ABL signaling	24826799	CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5	AP-24534	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24826799"" target= ""_blank"">PubChem</a>"	
157	JNK-9L	JNK-9L	KIN001-204	targeted	experimental	JNK	JNK and p38 signaling	146156476	C1COCCN1C2=CC(=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5C=NC(=N5)N6CCOCC6)F	JNK-9L	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/146156476"" target= ""_blank"">PubChem</a>"	
163	JQ1	JQ1		targeted	experimental	BRD4	chromatin  other	46907787	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C	JQ1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46907787"" target= ""_blank"">PubChem</a>"	
166	FTI-277	FTI-277		targeted	experimental	Farnesyl transferase (FNTA)	other	3005532	COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2	FTI-277	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/3005532"" target= ""_blank"">PubChem</a>"	
1372	Trametinib	Trametinib	"Mekinist, GSK1120212"	targeted	clinically approved	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	11707110	CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5	Trametinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11707110"" target= ""_blank"">PubChem</a>"	
154	CHIR-99021	CHIR-99021	CT 99021	targeted	experimental	GSK3B	WNT signaling	9956119	CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N	CHIR-99021	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9956119"" target= ""_blank"">PubChem</a>"	
170	Shikonin	Shikonin		not defined	in clinical development	unknown	other	479503	CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C	Shikonin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/479503"" target= ""_blank"">PubChem</a>"	Updated
171	AKT inhibitor VIII	AKT_inhibitor_VIII		targeted	in clinical development	"AKT1, AKT2, AKT3"	PI3K signaling	135398501	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8	AKT_inhibitor_VIII	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/ 135398501  "" target= ""_blank"">PubChem</a>"	
147	NSC-87877	NSC-87877		targeted	experimental	"PTPN6 (SHP-1), PTPN11 (SHP-2)"	other	92577	C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)S(=O)(=O)O	NSC-87877	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/ 92577"" target= ""_blank"">PubChem</a>"	Updated
156	AZD6482	AZD6482	KIN001-193	targeted	in clinical development	PI3Kbeta	PI3K signaling	44137675	CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4	AZD6482	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44137675"" target= ""_blank"">PubChem</a>"	
159	HG-6-64-1	HG-6-64-1	KIN001-206	targeted	experimental	"BRAFV600E, TAK, MAP4K5"	ERK MAPK signaling	53302361	CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)/C=C/C4=CN=C5C(=C4OC)C=CN5)C(F)(F)F	HG-6-64-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/53302361"" target= ""_blank"">PubChem</a>"	
165	DMOG	DMOG	Dimethyloxalylglcine	targeted	experimental	Prolyl-4-Hydroxylase	other	560326	COC(=O)CNC(=O)C(=O)OC	DMOG	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/560326"" target= ""_blank"">PubChem</a>"	
164	JQ12	JQ12		targeted	experimental	HDAC	chromain  histone acetylation	NA	NA	JQ12	NA	Compound not found
136	Mitomycin C	Mitomycin_C	"Mytozytrex,NSC-26980"	cytotoxic	clinically approved	DNA crosslinker	DNA replication	5746	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N	Mitomycin_C	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5746"" target= ""_blank"">PubChem</a>"	
172	Embelin	Embelin		targeted	in clinical development	XIAP	apoptosis regulation	3218	CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O	Embelin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/3218"" target= ""_blank"">PubChem</a>"	
200	LAQ824	LAQ824	"Dacinostat, NVP-LAQ824"	targeted	in clinical development	HDAC	chromain  histone acetylation	6445533	C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)/C=C/C(=O)NO	LAQ824	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6445533"" target= ""_blank"">PubChem</a>"	
133	Doxorubicin	Doxorubicin	"Adriamycin, Doxil,Rubex"	cytotoxic	clinically approved	DNA intercalating	DNA replication	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	Doxorubicin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/31703"" target= ""_blank"">PubChem</a>"	
151	QS11	QS11		targeted	experimental	ARFGAP	other	42623900	C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)N[C@@H](CC7=CC=CC=C7)CO	QS11	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/42623900"" target= ""_blank"">PubChem</a>"	Updated
201	Epothilone B	Epothilone_B	"GNF-PF-193, EPO906, Patupilone"	cytotoxic	in clinical development	Microtubules	cytoskeleton	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	Epothilone_B	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/448013"" target= ""_blank"">PubChem</a>"	
202	GSK-1904529A	GSK-1904529A		targeted	experimental	IGF1R	IGFR signaling	25124816	CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F	GSK-1904529A	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25124816"" target= ""_blank"">PubChem</a>"	
150	Bicalutamide	Bicalutamide	"Casodex, ICI-176334"	targeted	clinically approved	ANDR (androgen receptor)	other	2375	CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	Bicalutamide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/2375"" target= ""_blank"">PubChem</a>"	
167	OSU-03012	OSU-03012	AR-12	targeted	experimental	PDPK1 (PDK1)	PI3K signaling	10027278	C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F	OSU-03012	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10027278"" target= ""_blank"">PubChem</a>"	
176	IPA-3	IPA-3		targeted	experimental	"PAK1, PAK2, PAK3"	cytoskeleton	521106	C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O	IPA-3	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/521106"" target= ""_blank"">PubChem</a>"	
192	LFM-A13	LFM-A13	DDE-28	targeted	experimental	BTK	other	54676905	C/C(=C(\C#N)/C(=O)NC1=C(C=CC(=C1)Br)Br)/O	LFM-A13	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/54676905"" target= ""_blank"">PubChem</a>"	Updated
1527	GDC0941 (rescreen)	GDC0941_(rescreen)		targeted	in clinical development	PI3K	PI3K signaling	17755052	CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6	GDC0941_(rescreen)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/17755052"" target= ""_blank"">PubChem</a>"	
204	Tipifarnib	Tipifarnib	"Zarnestra,IND58359,R115777"	targeted	in clinical development	Farnesyl-transferase (FNTA)	other	159324	CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N	Tipifarnib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/159324"" target= ""_blank"">PubChem</a>"	
173	FH535	FH535		not defined	experimental	unknown 	other	3463933	CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl	FH535	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/3463933"" target= ""_blank"">PubChem</a>"	Compound not find
178	BAY 61-3606	BAY_61-3606		targeted	experimental	SYK	other	10200390	COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC	BAY_61-3606	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10200390"" target= ""_blank"">PubChem</a>"	
199	Pazopanib	Pazopanib	"Votrient, GW786034"	targeted	in clinical development	"VEGFR, PDGFRA, PDGFRB, KIT"	RTK signaling	10113978	CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N	Pazopanib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10113978"" target= ""_blank"">PubChem</a>"	
207	AS601245	AS601245		targeted	experimental	JNK 	JNK and p38 signaling	10109823	C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4	AS601245	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10109823"" target= ""_blank"">PubChem</a>"	
184	BMS-754807	BMS-754807		targeted	in clinical development	IGF1R	IGFR signaling	24785538	C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F	BMS-754807	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24785538"" target= ""_blank"">PubChem</a>"	
185	OSI-906	OSI-906	"Lisitinib, OSI-906"	targeted	in clinical development	IGF1R	IGFR signaling	11640390	CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O	OSI-906	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11640390"" target= ""_blank"">PubChem</a>"	Compound not found
135	Gemcitabine	Gemcitabine	"Gemzar, LY-188011"	cytotoxic	clinically approved	DNA replication	DNA replication	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Gemcitabine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/60750"" target= ""_blank"">PubChem</a>"	
197	Bryostatin 1	Bryostatin_1	NSC 339555	targeted	in clinical development	PRKC	other	5280757	CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)/C[C@H]2C[C@@H](OC(=O)C[C@@H](C[C@@H]3C[C@@H](C([C@@](O3)(C[C@@H]4C/C(=C/C(=O)OC)/C[C@@H](O4)/C=C/C([C@@]1(O2)O)(C)C)O)(C)C)OC(=O)C)O)[C@@H](C)O	Bryostatin_1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5280757"" target= ""_blank"">PubChem</a>"	
182	Obatoclax Mesylate	Obatoclax_Mesylate	GX15-070	targeted	in clinical development	"BCL2, BCL2L1, MCL1"	apoptosis regulation	16681698	CC1=CC(=C(N1)/C=C\2/C(=C/C(=C/3\C=C4C=CC=CC4=N3)/N2)OC)C.CS(=O)(=O)O 	Obatoclax_Mesylate	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16681698"" target= ""_blank"">PubChem</a>"	
190	Bleomycin	Bleomycin		cytotoxic	clinically approved	DNA damage	DNA replication	5360373	CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O	Bleomycin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5360373"" target= ""_blank"">PubChem</a>"	
158	PF-562271	PF-562271	KIN001-205	targeted	experimental	FAK	cytoskeleton	11713159	CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C	PF-562271	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11713159"" target= ""_blank"">PubChem</a>"	
177	GSK-650394	GSK-650394		targeted	experimental	SGK3	other	25022668	C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=C3C=C(C=N4)C5=CC=CC=C5)C(=O)O	GSK-650394	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25022668"" target= ""_blank"">PubChem</a>"	
194	AUY922	AUY922	"VER-52296,NVP-AUY922"	targeted	in clinical development	HSP90	other	135539077	CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C	AUY922	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/ 135539077"" target= ""_blank"">PubChem</a>"	Updated
1526	RDEA119 (rescreen)	RDEA119_(rescreen)		targeted	experimental	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	44182295	COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F	RDEA119_(rescreen)	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44182295"" target= ""_blank"">PubChem</a>"	
150	Bicalutamide	Bicalutamide	"Casodex, ICI-176334"	targeted	clinically approved	ANDR (androgen receptor)	other	2375	CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	Bicalutamide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/2375"" target= ""_blank"">PubChem</a>"	
175	PAC-1	PAC-1		targeted	in clinical development	CASP3 agonist	apoptosis regulation	135421197	C=CCC1=CC=CC(=CNNC(=O)CN2CCN(CC2)CC3=CC=CC=C3)C1=O	PAC-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135421197"" target= ""_blank"">PubChem</a>"	Updated
186	Bexarotene	Bexarotene	"Targretin, LG-100069,LGD-1069"	targeted	clinically approved	Retinioic acid X family agonist	other	82146	CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C	Bexarotene	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/82146"" target= ""_blank"">PubChem</a>"	
1114	Cetuximab	Cetuximab	Erbitux	targeted	clinically approved	EGFR	EGFR signaling	136170999	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O.C1=C(C(=O)NC(=O)N1)	Cetuximab	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/136170999"" target= ""_blank"">PubChem</a>"	Updated
1373	Dabrafenib	Dabrafenib	"Tafinlar, GSK2118436"	targeted	clinically approved	BRAF	ERK MAPK signaling	44462760	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F	Dabrafenib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44462760"" target= ""_blank"">PubChem</a>"	
180	Thapsigargin	Thapsigargin		targeted	experimental	sarco-endoplasmic reticulum Ca2+-ATPases	other	446378	CCCCCCCC(=O)O[C@H]1[C@H]2C(=C([C@@H]1OC(=O)/C(=C\C)/C)C)[C@H]3[C@]([C@H](C[C@]2(C)OC(=O)C)OC(=O)CCC)([C@](C(=O)O3)(C)O)O	Thapsigargin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/446378"" target= ""_blank"">PubChem</a>"	Updated
1012	Vorinostat	Vorinostat	"Zolinza, SAHA"	targeted	clinically approved	"HDAC inhibitor Class I, IIa, IIb, IV"	chromain  histone acetylation	5311	C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO	Vorinostat	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5311"" target= ""_blank"">PubChem</a>"	
1019	Bosutinib	Bosutinib	"Bosulif, SKI-606"	targeted	clinically approved	"SRC, ABL, TEC"	ABL signaling	5328940	CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC	Bosutinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5328940"" target= ""_blank"">PubChem</a>"	
1020	Lenalidomide	Lenalidomide	Revlimid	targeted	clinically approved	TNFA	other	216326	C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N	Lenalidomide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/216326"" target= ""_blank"">PubChem</a>"	
1004	Vinblastine	Vinblastine	Vinblastine sulphate	cytotoxic	clinically approved	Microtubules	cytoskeleton	13342	CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Vinblastine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/13342"" target= ""_blank"">PubChem</a>"	Updated
1005	Cisplatin	Cisplatin	"cisplatin, cis-Diammineplatinum(II) dichloride"	cytotoxic	clinically approved	DNA crosslinker	DNA replication	5702198	N.N.[Cl-].[Cl-].[Pt+2]	Cisplatin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5702198"" target= ""_blank"">PubChem</a>"	Updated
1007	Docetaxel	Docetaxel	RP-56976	cytotoxic	clinically approved	Microtubules	cytoskeleton	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Docetaxel	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/148124"" target= ""_blank"">PubChem</a>"	
1017	Olaparib	Olaparib	"Lynparza, KU0059436, AZD-2281"	targeted	in clinical development	"PARP1, PARP2"	Genome integrity	23725625	C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F	Olaparib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/23725625"" target= ""_blank"">PubChem</a>"	
1018	ABT-888	ABT-888	Veliparib	targeted	in clinical development	"PARP1, PARP2"	Genome integrity	45480520	 C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N.Cl.Cl	ABT-888	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/45480520"" target= ""_blank"">PubChem</a>"	
1026	17-AAG	17-AAG	"Telatinib, tanespimycin"	targeted	in clinical development	HSP90	other	6505803	C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC	17-AAG	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6505803"" target= ""_blank"">PubChem</a>"	
1033	Vismodegib	Vismodegib	Erivedge	targeted	in clinical development	SMO	other	24776445	CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl	Vismodegib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24776445"" target= ""_blank"">PubChem</a>"	
1003	Camptothecin	Camptothecin	"7-Ethyl-10-Hydroxy-Camptothecin,SN-38"	cytotoxic	clinically approved	TOP1	DNA replication	24360	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O	Camptothecin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24360"" target= ""_blank"">PubChem</a>"	
1008	Methotrexate	Methotrexate		cytotoxic	clinically approved	Dihydrofolate reductase (DHFR)	DNA replication	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Methotrexate	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/126941"" target= ""_blank"">PubChem</a>"	
1011	ABT-263	ABT-263	Navitoclax	targeted	in clinical development	"BCL2, BCL2L1, BCL2L2"	apoptosis regulation	24978538	CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C	ABT-263	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24978538"" target= ""_blank"">PubChem</a>"	
1022	AZD7762	AZD7762		targeted	in clinical development	"CHEK1, CHEK2"	Genome integrity	11152667	C1C[C@@H](CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N	AZD7762	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11152667"" target= ""_blank"">PubChem</a>"	
1024	CEP-701	CEP-701	Lestaurtinib	targeted	in clinical development	"FLT3, JAK2, NTRK1, RET"	RTK signaling	126565	C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O	CEP-701	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/126565"" target= ""_blank"">PubChem</a>"	
1029	AMG-706	AMG-706	Motesanib Diphosphate	targeted	in clinical development	"VEGFR, RET, c-KIT, PDGFR"	RTK signaling	11667893	CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C	AMG-706	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11667893"" target= ""_blank"">PubChem</a>"	
1031	Elesclomol	Elesclomol		targeted	in clinical development	HSP70	other	300471	CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2	Elesclomol	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/300471"" target= ""_blank"">PubChem</a>"	
1032	Afatinib	Afatinib	"Gilotrif, BIBW2992, Tovok"	targeted	clinically approved	"ERBB2, EGFR"	EGFR signaling	10184653	CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4	Afatinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10184653"" target= ""_blank"">PubChem</a>"	
1037	BX-795	BX-795		targeted	in clinical development	"TBK1, PDPK1, IKK, AURKB, AURKC"	other	10077147	C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I	BX-795	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10077147"" target= ""_blank"">PubChem</a>"	
1047	Nutlin-3a	Nutlin-3a		targeted	in clinical development	MDM2	p53 pathway	11433190	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	Nutlin-3a	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11433190"" target= ""_blank"">PubChem</a>"	
1049	PD-173074	PD-173074		targeted	experimental	"FGFR1, FGFR3"	RTK signaling	1401	CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C	PD-173074	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/1401"" target= ""_blank"">PubChem</a>"	
1052	RO-3306	RO-3306		targeted	experimental	CDK1	cell cycle	135400873	C1=CC2=C(C=CC(=C2)/C=C/3\C(=O)N=C(S3)NCC4=CC=CS4)N=C1	RO-3306	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135400873"" target= ""_blank"">PubChem</a>"	
1030	KU-55933	KU-55933		targeted	experimental	ATM	Genome integrity	5278396	C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4	KU-55933	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5278396"" target= ""_blank"">PubChem</a>"	
1036	PLX4720	PLX4720	"vemurafenib analog, Zelboraf (derivative)"	targeted	clinically approved	BRAF	ERK MAPK signaling	24180719	CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F	PLX4720	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24180719"" target= ""_blank"">PubChem</a>"	
1021	Axitinib	Axitinib	AG-013736	targeted	in clinical development	"PDGFR, KIT, VEGFR"	RTK signaling	6450551	CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4	Axitinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6450551"" target= ""_blank"">PubChem</a>"	
1023	GW 441756	GW_441756		targeted	experimental	NTRK1	RTK signaling	9943465	CN1C=C(C2=CC=CC=C21)/C=C\3/C4=C(C=CC=N4)NC3=O	GW_441756	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9943465"" target= ""_blank"">PubChem</a>"	Updated
1028	VX-702	VX-702		targeted	in clinical development	p38	JNK and p38 signaling	10341154	C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F	VX-702	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10341154"" target= ""_blank"">PubChem</a>"	
1043	JNK Inhibitor VIII	JNK_Inhibitor_VIII		targeted	experimental	JNK	JNK and p38 signaling	11624601	CCOC1=C(C(=CC(=N1)NC(=O)CC2=C(C=CC(=C2)OC)OC)N)C#N	JNK_Inhibitor_VIII	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11624601"" target= ""_blank"">PubChem</a>"	
1006	Cytarabine	Cytarabine	"Ara-Cytidine,Arabinosyl Cytosine,U-19920"	cytotoxic	clinically approved	DNA synthesis	DNA replication	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Cytarabine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6253"" target= ""_blank"">PubChem</a>"	
1010	Gefitinib	Gefitinib	"Iressa, ZD-1839"	targeted	clinically approved	EGFR	EGFR signaling	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Gefitinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/123631"" target= ""_blank"">PubChem</a>"	
1038	NU-7441	NU-7441	KU-57788	targeted	experimental	PRKDC (DNAPK)	Genome integrity	11327430	C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56	NU-7441	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11327430"" target= ""_blank"">PubChem</a>"	
1057	NVP-BEZ235	NVP-BEZ235	BEZ235	targeted	in clinical development	PI3K (Class 1) and MTORC1/2	PI3K signaling	11977753	CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5	NVP-BEZ235	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11977753"" target= ""_blank"">PubChem</a>"	
1058	GDC0941	GDC0941		targeted	in clinical development	PI3K (class 1)	PI3K signaling	17755052	CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6	GDC0941	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/17755052"" target= ""_blank"">PubChem</a>"	
1059	AZD8055	AZD8055	pp242	targeted	in clinical development	MTORC1/2	TOR signaling	25262965	C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C	AZD8055	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/25262965"" target= ""_blank"">PubChem</a>"	
1060	PD-0325901	PD-0325901		targeted	in clinical development	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	9826528	C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O	PD-0325901	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9826528"" target= ""_blank"">PubChem</a>"	
1001	AICAR	AICAR		targeted	in clinical development	AAPK1 (AMPK) agonist	metabolism	17513	C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N	AICAR	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/17513 "" target= ""_blank"">PubChem</a>"	Updated
1009	ATRA	ATRA	"Tretinoin, Vesanoid"	targeted	clinically approved	Retinoic acid and retinoid X receptor agonist	other	444795	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	ATRA	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/444795"" target= ""_blank"">PubChem</a>"	
1014	RDEA119	RDEA119		targeted	in clinical development	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	44182295	COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F	RDEA119	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44182295"" target= ""_blank"">PubChem</a>"	
1015	CI-1040	CI-1040	"PD-18435,PD-184352"	targeted	in clinical development	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	6918454	C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl	CI-1040	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6918454"" target= ""_blank"">PubChem</a>"	
1042	BIRB 0796	BIRB_0796	Doramapimod	targeted	experimental	"p38, JNK2"	JNK and p38 signaling	156422	CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5	BIRB_0796	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/156422"" target= ""_blank"">PubChem</a>"	
1016	Temsirolimus	Temsirolimus	"Torisel, CCI-779"	targeted	clinically approved	MTOR	TOR signaling	6918289	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC	Temsirolimus	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/6918289"" target= ""_blank"">PubChem</a>"	
1039	SL 0101-1	SL_0101-1		targeted	experimental	"RSK, AURKB, PIM3"	ERK MAPK signaling	10459196	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C	SL_0101-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10459196"" target= ""_blank"">PubChem</a>"	
1061	SB590885	SB590885		targeted	experimental	BRAF	ERK MAPK signaling	35421339	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC5=C(C=C4)/C(=N/O)/CC5	SB590885	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/35421339"" target= ""_blank"">PubChem</a>"	Updated
1053	MK-2206	MK-2206		targeted	in clinical development	"AKT1, AKT2"	PI3K signaling	24964624	C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N	MK-2206	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24964624"" target= ""_blank"">PubChem</a>"	Updated
1054	PD-0332991	PD-0332991	Palbociclib Isethionate	targeted	in clinical development	"CDK4, CDK6"	cell cycle	5330286	CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C	PD-0332991	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5330286"" target= ""_blank"">PubChem</a>"	
1062	AZD6244	AZD6244	selumetinib	targeted	in clinical development	"MAP2K1 (MEK1), MAP2K2 (MEK2)"	ERK MAPK signaling	10127622	CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO	AZD6244	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10127622"" target= ""_blank"">PubChem</a>"	
231	FMK	FMK	KIN001-242	targeted	experimental	RSK	ERK MAPK signaling	644243	CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CF	FMK	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/644243"" target= ""_blank"">PubChem</a>"	
1013	Nilotinib	Nilotinib	Tasigna	targeted	clinically approved	ABL	ABL signaling	644241	CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Nilotinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/644241"" target= ""_blank"">PubChem</a>"	
1050	ZM-447439	ZM-447439		targeted	experimental	AURKB	mitosis	9914412	COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5	ZM-447439	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9914412"" target= ""_blank"">PubChem</a>"	
1239	YK 4-279	YK_4-279		targeted	experimental	RNA helicase A	other	44632017	COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O	YK_4-279	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/44632017"" target= ""_blank"">PubChem</a>"	
1046	681640	681640		targeted	experimental	"WEE1, CHEK1"	cell cycle	10384072	C1=CC=C(C(=C1)C2=CC3=C(C4=C(N3)C=CC(=C4)O)C5=C2C(=O)NC5=O)Cl	681640	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10384072"" target= ""_blank"">PubChem</a>"	Compound name not found but was able to trace with CID
1025	SB 216763	SB_216763		targeted	experimental	"GSK3A, GSK3B"	WNT signaling	176158	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl	SB_216763	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/176158"" target= ""_blank"">PubChem</a>"	
1529	MLN4924	MLN4924	Pevonedistat	targeted	in clinical development	NEDD8-activating enzyme	other	16720766	C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N	MLN4924	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16720766"" target= ""_blank"">PubChem</a>"	
1166	QL-VIII-58	QL-VIII-58		targeted	experimental	"MTOR, ATR"	TOR signaling	NA	NA	QL-VIII-58	NA	Compound not found
1164	XMD8-92	XMD8-92		targeted	experimental	MAP2K5 (ERK5)	other	46843772	CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C	XMD8-92	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46843772"" target= ""_blank"">PubChem</a>"	
1142	HG-5-113-01	HG-5-113-01		targeted	in clinical development	"LOK, LTK, TRCB, ABL(T315I)"	ABL signaling	NA	NA	HG-5-113-01	NA	Compound not found
1158	XMD11-85h	XMD11-85h		targeted	experimental	"BRSK2, FLT4, MARK4, PRKCD, RET, SPRK1"	other	NA	NA	XMD11-85h	NA	Compound not found
1161	ZG-10	ZG-10		targeted	experimental	IRAK1	other	57340680	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	ZG-10	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/57340680"" target= ""_blank"">PubChem</a>"	
1143	HG-5-88-01	HG-5-88-01		targeted	experimental	"EGFR, ADCK4"	EGFR signaling	NA	NA	HG-5-88-01	NA	Compound not found
1203	QL-XII-61	QL-XII-61		targeted	experimental	BTK	other	NA	NA	QL-XII-61	NA	Compound not found
6	PHA-665752	PHA-665752		targeted	experimental	MET	RTK signaling	10461815	CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O	PHA-665752	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10461815"" target= ""_blank"">PubChem</a>"	
35	NVP-TAE684	NVP-TAE684	TAE684	targeted	experimental	ALK	RTK signaling	16038120	CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC	NVP-TAE684	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16038120"" target= ""_blank"">PubChem</a>"	
37	Crizotinib	Crizotinib	"Xalkori,PF2341066"	targeted	in clinical development	"MET, ALK"	RTK signaling	11626560	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N	Crizotinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11626560"" target= ""_blank"">PubChem</a>"	
34	Imatinib	Imatinib	"Gleevec,STI-571"	targeted	clinically approved	"ABL, KIT, PDGFR"	ABL signaling	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Imatinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5291"" target= ""_blank"">PubChem</a>"	
38	AZD-0530	AZD-0530	"AZD-0530,KIN001-045"	targeted	in clinical development	"SRC, ABL1"	ABL signaling	10302451	CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl	AZD-0530	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10302451"" target= ""_blank"">PubChem</a>"	
29	AZ628	AZ628		targeted	experimental	BRAF	ERK MAPK signaling	11676786	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(C)(C)C#N)NC3=CC4=C(C=C3)N=CN(C4=O)C	AZ628	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11676786"" target= ""_blank"">PubChem</a>"	
89	Parthenolide	Parthenolide		targeted	in clinical development	NFKB1	other	7251185	C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C	Parthenolide	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/7251185"" target= ""_blank"">PubChem</a>"	
91	KIN001-135	KIN001-135		targeted	experimental	IKKE	other	11626927	COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC	KIN001-135	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11626927"" target= ""_blank"">PubChem</a>"	Compound not found
30	Sorafenib	Sorafenib	"BAY-439006, Nexavar"	targeted	clinically approved	"PDGFRA, PDGFRB, KDR, KIT, FLT3"	RTK signaling	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Sorafenib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/216239"" target= ""_blank"">PubChem</a>"	
104	Bortezomib	Bortezomib	"Velcade, LDP-341,PS-341"	targeted	clinically approved	Proteasome	other	387447	B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O	Bortezomib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/387447"" target= ""_blank"">PubChem</a>"	
127	GSK269962A	GSK269962A	KIN001-155	targeted	experimental	"ROCK1, ROCK2"	cytoskeleton	16095342	CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6	GSK269962A	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16095342"" target= ""_blank"">PubChem</a>"	
9	MG-132	MG-132	zLLL	targeted	experimental	Proteasome	other	462382	CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	MG-132	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/462382"" target= ""_blank"">PubChem</a>"	
11	Paclitaxel	Paclitaxel	"Taxol, BMS-181339-01"	cytotoxic	clinically approved	Microtubules	cytoskeleton	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Paclitaxel	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/36314"" target= ""_blank"">PubChem</a>"	
55	A-770041	A-770041	KIN001-111	targeted	experimental	SRC family	other	9549184	CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)N	A-770041	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9549184"" target= ""_blank"">PubChem</a>"	
63	BMS-509744	BMS-509744	KIN001-127	targeted	experimental	ITK	other	11467730	CC1=CC(=C(C=C1SC2=CN=C(S2)NC(=O)C3=CC=C(C=C3)CNC(C)C(C)(C)C)C(=O)N4CCN(CC4)C(=O)C)OC	BMS-509744	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11467730"" target= ""_blank"">PubChem</a>"	Updated
71	Pyrimethamine	Pyrimethamine	Daraprim	cytotoxic	clinically approved	Dihydrofolate reductase (DHFR)	DNA replication	4993	CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl	Pyrimethamine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/4993"" target= ""_blank"">PubChem</a>"	
87	GW843682X	GW843682X	KIN001-134	targeted	experimental	PLK1	mitosis	9826308	COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC	GW843682X	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9826308"" target= ""_blank"">PubChem</a>"	
88	MS-275	MS-275		targeted	in clinical development	HDAC	chromain  histone acetylation	4261	C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3	MS-275	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/4261"" target= ""_blank"">PubChem</a>"	
94	TGX221	TGX221		targeted	experimental	PI3Kbeta	PI3K signaling	9907093	CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4	TGX221	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/9907093"" target= ""_blank"">PubChem</a>"	
5	Sunitinib	Sunitinib	Sutent	targeted	clinically approved	"PDGFRA, PDGFRB, KDR, KIT, FLT3"	RTK signaling	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C 	Sunitinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5329102"" target= ""_blank"">PubChem</a>"	Updated
45	Z-LLNle-CHO	Z-LLNle-CHO	Z-L-Norleucine-CHO	targeted	experimental	g-secretase	other	11754711	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	Z-LLNle-CHO	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11754711"" target= ""_blank"">PubChem</a>"	Updated
53	CGP-60474	CGP-60474	KIN001-019	targeted	experimental	"CDK1,CDK2,CDK5,CDK7,CDK9"	cell cycle	644215	C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO	CGP-60474	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/644215"" target= ""_blank"">PubChem</a>"	
54	CGP-082996	CGP-082996	"CINK4,KIN001-021"	targeted	experimental	CDK4	cell cycle	24825971	CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O	CGP-082996	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/24825971"" target= ""_blank"">PubChem</a>"	
59	WZ-1-84	WZ-1-84	KIN001-123	targeted	experimental	BMX	other	49821040	CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3	WZ-1-84	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/49821040"" target= ""_blank"">PubChem</a>"	Compound not found
62	BMS-536924	BMS-536924	KIN001-126	targeted	experimental	IGF1R	IGFR signaling	135440466	CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5	BMS-536924	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/135440466"" target= ""_blank"">PubChem</a>"	
64	CMK	CMK	KIN001-128	targeted	experimental	RSK	ERK MAPK signaling	16663089	CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl	CMK	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/16663089"" target= ""_blank"">PubChem</a>"	
86	A-443654	A-443654	KIN001-139	targeted	experimental	"AKT1, AKT2, AKT3"	PI3K signaling	10172943	CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N	A-443654	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/10172943"" target= ""_blank"">PubChem</a>"	
41	S-Trityl-L-cysteine	S-Trityl-L-cysteine	NSC 83265	targeted	experimental	KIF11	mitosis	76044	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SC[C@@H](C(=O)O)N	S-Trityl-L-cysteine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/76044"" target= ""_blank"">PubChem</a>"	
60	BI-2536	BI-2536	"NPK33-1-98-1, KIN001-124"	targeted	in clinical development	"PLK1, PLK2, PLK3"	mitosis	11364421	CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C	BI-2536	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11364421"" target= ""_blank"">PubChem</a>"	
52	GNF-2	GNF-2		targeted	experimental	ABL [T315I]	ABL signaling	5311510	C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F	GNF-2	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5311510"" target= ""_blank"">PubChem</a>"	
56	WH-4-023	WH-4-023	KIN001-112	targeted	experimental	"SRC family, ABL"	ABL signaling	11844351	CC1=C(C(=CC=C1)C)OC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(CC5)C	WH-4-023	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/11844351"" target= ""_blank"">PubChem</a>"	
111	Salubrinal	SalubriNaN		targeted	experimental	GADD34-PP1C 	other	5717801	C1=CC=C(C=C1)/C=C/C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3	Salubrinal	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5717801"" target= ""_blank"">PubChem</a>"	
51	Dasatinib	Dasatinib	"Sprycel, KIN001-005"	targeted	clinically approved	"ABL, SRC, KIT, PDGFR"	ABL signaling	3062316	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO	Dasatinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/3062316"" target= ""_blank"">PubChem</a>"	
106	XMD8-85	XMD8-85		targeted	experimental	MAP2K5 (ERK5)	other	46844147	CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C)OC	XMD8-85	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/46844147"" target= ""_blank"">PubChem</a>"	
110	Roscovitine	Roscovitine	Seliciclib	targeted	in clinical development	CDKs	cell cycle	160355	CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3	Roscovitine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/160355"" target= ""_blank"">PubChem</a>"	
119	Lapatinib	Lapatinib	"Tykerb, Tyverb"	targeted	clinically approved	"ERBB2, EGFR"	EGFR signaling	208908	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	Lapatinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/208908"" target= ""_blank"">PubChem</a>"	
17	Cyclopamine	Cyclopamine	11-deoxojervine	targeted	experimental	SMO	other	442972	C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1	Cyclopamine	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/442972"" target= ""_blank"">PubChem</a>"	
32	VX-680	VX-680	"MK-045,MK-0457,VX-68"	targeted	in clinical development	"AURKA, AURKB, AURKC, FLT3, ABL1, JAK2"	mitosis	5494449	CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C	VX-680	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5494449"" target= ""_blank"">PubChem</a>"	
83	JW-7-52-1	JW-7-52-1		targeted	experimental	MTOR	TOR signaling	49836027	CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F	JW-7-52-1	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/49836027"" target= ""_blank"">PubChem</a>"	Compound not found
1	Erlotinib	Erlotinib	NA	targeted	clinically approved	EGFR	EGFR signaling	176870	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Erlotinib	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/176870"" target= ""_blank"">PubChem</a>"	
3	Rapamycin	Rapamycin	"Rapamune, AY-22989,Sirolimus,WY-090217"	targeted	clinically approved	MTOR	TOR signaling	5284616	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Rapamycin	"<a href=""https://pubchem.ncbi.nlm.nih.gov/compound/5284616"" target= ""_blank"">PubChem</a>"	Updated
